Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis

Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis

Abstract The Mayo-2018 smoldering multiple myeloma (SMM) risk score is used routinely in the clinical setting but has only been validated at diagnosis. In SMM patients, the progression risk decreases over time. However, the utility of applying risk stratification models after diagnosis is unknown. W...

Full description

Bibliographic Details
Main Authors: Alissa Visram, S. Vincent Rajkumar, Prashant Kapoor, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, David Dingli, Taxiarchis Kourelis, Wilson Gonsalves, Rahma Warsame, Eli Muchtar, Nelson Leung, Linda B. Baughn, Robert A. Kyle, Shaji Kumar
Format: Article
Language:English
Published: Nature Publishing Group 2021-11-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-021-00569-2

Internet

https://doi.org/10.1038/s41408-021-00569-2

Similar Items